Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Hunter Syndrome Treatment Market
Hunter Syndrome Treatment Market Trends
- Report ID: GMI10514
- Published Date: Jul 2024
- Report Format: PDF
Hunter Syndrome Treatment Market Trends
The ongoing development and approval of innovative therapies are transforming the management of Hunter syndrome.
- One of the most notable advancements in the treatment of Hunter syndrome is the development of enzyme replacement therapy (ERT). ERT involves the regular infusion of a synthetic enzyme to replace the deficient iduronate-2-sulfatase in patients.
- This therapy has been shown to improve clinical outcomes, including reduced organ enlargement, improved respiratory function, and enhanced quality of life. The introduction of ERT has been a game-changer in the management of Hunter syndrome, driving the growth of the treatment market.
- Additionally, hematopoietic stem cell therapy is another advanced treatment option for Hunter syndrome. HSCT involves the transplantation of healthy stem cells that can produce the missing enzyme.
- While this procedure is complex and associated with significant risks, it has the potential to provide lasting therapeutic benefits. Ongoing research and improvements in HSCT techniques are enhancing its safety and efficacy, contributing to its role as a growth driver in the market.
Frequently Asked Questions (FAQ) :
Hunter syndrome treatment market was valued at USD 845.8 million in 2023 and is anticipated to witness growth at 5.9% CAGR during 2024-2032 driven by the increasing prevalence of hunter syndrome coupled with rising R&D expenditure.
The hospitals segment in the market was valued at USD 492.5 million in 2023 as they offer a range of treatment options, including enzyme replacement therapy (ERT).
North America hunter syndrome treatment market size was valued at USD 403.5 million in 2023 and is predicted to grow at 5.4% CAGR during 2024-2032 driven by the advanced healthcare infrastructure.
Astellas Pharma Inc., B.Braun, Baxter International, CHIESI Farmaceutici S.p.A., Fresenius Kabi, GC Pharma, JCR Pharmaceuticals, Takeda Pharmaceutical Company Limited, Terumo Corporation, and Thermo Fisher Scientific
Hunter Syndrome Treatment Market Scope
×
Get a free sample of
Hunter Syndrome Treatment Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below